Of interest, deletion polymorphism encompassing the large part of LILRA3, a soluble receptor which possibly antagonizes binding of sHLA-G and LILRB1/LILRB2, has been associated with a variety of immune system disorders [37]. This evidence concerns the gene HLA-G and immune system disorder.